Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
BiologicsGene Therapeutics & RNAi

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1427062

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1427062

Lentiviral Vectors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 234 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

Global Market Insights and Trends

The lentiviral vectors market is poised for remarkable expansion, according to recent industry analysis. With a valuation of US$ 160 million in 2024 and a projected compound annual growth rate (CAGR) of 14% over the next decade, the market is set to reach an impressive US$ 400 million by 2031. Kits, constituting three-fourths of the market share, emerged as a dominant product segment in 2023. Lentiviral vectors' consumption accounted for a substantial 20.1% share of the global viral vectors manufacturing market in 2023.

Unveiling Opportunities for Lentiviral Vector Manufacturers

One of the most significant opportunities lies in the surge in demand for lentiviral vectors in T cell engineering for cancer treatment. Lentiviral vectors have become instrumental in gene-modified cell-based therapies, particularly in the realm of T cell therapies. These vectors play a crucial role in conveying Chimeric Antigen Receptors (CARs) or cloned T-cell receptors to mature T cells, facilitating the creation of anti-cancer immunity. Notably, the FDA's approval of the first genetically-engineered cellular therapy underscores the clinical effectiveness lentiviral vectors bring to patients with B-cell malignancies.

Moreover, lentiviral vectors continue to evolve alongside CAR T-cell therapy, demonstrating their potential as a potent supplementary tool in treating a broader spectrum of malignancies. The evolving landscape presents numerous opportunities for lentiviral vector manufacturers, particularly in emerging economies, where business expansion prospects are ripe.

Challenges in Market Expansion

Despite the promising growth trajectory, challenges persist, primarily concerning the high cost of gene therapy. While gene therapy holds immense potential in curing various illnesses and enhancing the body's ability to combat diseases, its cost remains a significant barrier. Gene therapy pricing, often determined on a case-by-case basis, lacks regulation, leading to substantial upfront payments. Factors such as development costs, disease characteristics, and associated expenses further complicate pricing strategies, potentially hindering market expansion.

Country-wise Insights

United States: Target for Strategic Acquisitions

The U.S. dominates the North America lentiviral vectors market, accounting for a significant 82% of its value. This high market share is attributed to the presence of major industry players within the country, ensuring ample product availability. Notably, strategic acquisitions and mergers among key players are driving market growth. For instance, in June 2021, Charles River Laboratories International, Inc. acquired Vigene Biosciences, Inc., enhancing its viral vector-based gene delivery solutions.

United Kingdom: Research Hub for Cancer Treatment

In the United Kingdom, the lentiviral vectors market held a substantial market share of 25.2% in Europe in 2021. The country stands as a hub for research activities, particularly in cancer treatment. Researchers in the UK are actively exploring the use of lentiviral vectors for T cell engineering to uncover novel cancer therapeutic options. These vectors, proven to be safe and effective for gene transfer, are integral to the advancement of CAR T cell treatments, contributing to the rapid expansion of the market in the UK.

China: Emerging Manufacturing Powerhouse

China is emerging as a prominent market for lentiviral vectors, accounting for 37.1% of the lentiviral vectors market share in East Asia. The region's rapid development of medical infrastructure and strategic planning for expansion are driving factors behind its flourishing lentiviral vectors industry. Notably, companies like GenScript ProBio are contributing to this growth with the construction of new manufacturing facilities, such as its 34,000-square-meter GMP manufacturing facility in Zhenjiang, Jiangsu. This underscores China's position as a key player in the global lentiviral vectors market.

Competitive Analysis and Key Players

Strategic collaborations, product launches, and acquisitions are central to increasing market presence among key lentiviral vector manufacturers. Companies such as Thermo Fisher Scientific, PerkinElmer Inc. (Sirion-Biotech GmbH), GENEMEDI, Takara Bio, Inc., Charles River Laboratories, Sino Biological Inc., OriGene Technologies, Inc., Cell BioLabs, Inc., and Applied Biological Materials Inc. are actively engaged in developing innovative lentiviral vector solutions to capture larger market shares.

  • Thermo Fisher Scientific
  • PerkinElmer Inc. (Sirion-Biotech GmbH)
  • GENEMEDI
  • Takara Bio, Inc.
  • Charles River Laboratories
  • Sino Biological Inc.
  • OriGene Technologies, Inc.
  • Cell BioLabs, Inc.
  • Applied Biological Materials Inc.

Key Segments Covered in Lentiviral Vectors Industry Survey

Lentiviral Vectors Market by Product:

  • Lentiviral Vector Kits
    • Lentiviral Packing Systems
    • Lentiviral Expression Systems
    • Lentiviral Promoter Kits
    • Lentiviral Fusion Tags
  • Reagents & Consumables

Lentiviral Vectors Market by Indication:

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Veterinary Diseases
  • Others

Lentiviral Vectors Market by End User:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes

Lentiviral Vectors Market by Region:

  • North America Lentiviral Vectors Market
  • Latin America Lentiviral Vectors Market
  • Europe Lentiviral Vectors Market
  • South Asia Lentiviral Vectors Market
  • East Asia Lentiviral Vectors Market
  • Oceania Lentiviral Vectors Market
  • Middle East & Africa Lentiviral Vectors Market
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Lentiviral Vectors Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Lentiviral Vectors Market Outlook, 2018 - 2031

  • 3.1. Global Lentiviral Vectors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Lentiviral Vector Kits
        • 3.1.1.1.1. Lentiviral Packing Systems
        • 3.1.1.1.2. Lentiviral Expression Systems
        • 3.1.1.1.3. Lentiviral Promoter Kits
        • 3.1.1.1.4. Lentiviral Fusion Tags
      • 3.1.1.2. Reagents & Consumables
  • 3.2. Global Lentiviral Vectors Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cancer
      • 3.2.1.2. Genetic Disorders
      • 3.2.1.3. Infectious Diseases
      • 3.2.1.4. Veterinary Diseases
      • 3.2.1.5. Others
  • 3.3. Global Lentiviral Vectors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Biotechnology Companies
      • 3.3.1.2. Pharmaceutical Companies
      • 3.3.1.3. Contract Research Organizations (CROs)
      • 3.3.1.4. Academic and Research Institutes
  • 3.4. Global Lentiviral Vectors Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Lentiviral Vectors Market Outlook, 2018 - 2031

  • 4.1. North America Lentiviral Vectors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Lentiviral Vector Kits
        • 4.1.1.1.1. Lentiviral Packing Systems
        • 4.1.1.1.2. Lentiviral Expression Systems
        • 4.1.1.1.3. Lentiviral Promoter Kits
        • 4.1.1.1.4. Lentiviral Fusion Tags
      • 4.1.1.2. Reagents & Consumables
  • 4.2. North America Lentiviral Vectors Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cancer
      • 4.2.1.2. Genetic Disorders
      • 4.2.1.3. Infectious Diseases
      • 4.2.1.4. Veterinary Diseases
      • 4.2.1.5. Others
  • 4.3. North America Lentiviral Vectors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Biotechnology Companies
      • 4.3.1.2. Pharmaceutical Companies
      • 4.3.1.3. Contract Research Organizations (CROs)
      • 4.3.1.4. Academic and Research Institutes
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Lentiviral Vectors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.2. U.S. Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.4.1.3. U.S. Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.4.1.4. Canada Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.5. Canada Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.4.1.6. Canada Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Lentiviral Vectors Market Outlook, 2018 - 2031

  • 5.1. Europe Lentiviral Vectors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Lentiviral Vector Kits
        • 5.1.1.1.1. Lentiviral Packing Systems
        • 5.1.1.1.2. Lentiviral Expression Systems
        • 5.1.1.1.3. Lentiviral Promoter Kits
        • 5.1.1.1.4. Lentiviral Fusion Tags
      • 5.1.1.2. Reagents & Consumables
  • 5.2. Europe Lentiviral Vectors Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cancer
      • 5.2.1.2. Genetic Disorders
      • 5.2.1.3. Infectious Diseases
      • 5.2.1.4. Veterinary Diseases
      • 5.2.1.5. Others
  • 5.3. Europe Lentiviral Vectors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Biotechnology Companies
      • 5.3.1.2. Pharmaceutical Companies
      • 5.3.1.3. Contract Research Organizations (CROs)
      • 5.3.1.4. Academic and Research Institutes
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Lentiviral Vectors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.2. Germany Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.4.1.3. Germany Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.4. U.K. Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.5. U.K. Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.4.1.6. U.K. Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.7. France Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.8. France Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.4.1.9. France Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.10. Italy Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.11. Italy Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.4.1.12. Italy Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.13. Turkey Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.14. Turkey Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.4.1.15. Turkey Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.16. Russia Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.17. Russia Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.4.1.18. Russia Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Lentiviral Vectors Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Lentiviral Vectors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Lentiviral Vector Kits
        • 6.1.1.1.1. Lentiviral Packing Systems
        • 6.1.1.1.2. Lentiviral Expression Systems
        • 6.1.1.1.3. Lentiviral Promoter Kits
        • 6.1.1.1.4. Lentiviral Fusion Tags
      • 6.1.1.2. Reagents & Consumables
  • 6.2. Asia Pacific Lentiviral Vectors Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cancer
      • 6.2.1.2. Genetic Disorders
      • 6.2.1.3. Infectious Diseases
      • 6.2.1.4. Veterinary Diseases
      • 6.2.1.5. Others
  • 6.3. Asia Pacific Lentiviral Vectors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Biotechnology Companies
      • 6.3.1.2. Pharmaceutical Companies
      • 6.3.1.3. Contract Research Organizations (CROs)
      • 6.3.1.4. Academic and Research Institutes
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Lentiviral Vectors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.2. China Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.4.1.3. China Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.4. Japan Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.5. Japan Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.4.1.6. Japan Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.7. South Korea Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.8. South Korea Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.4.1.9. South Korea Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.10. India Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.11. India Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.4.1.12. India Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Lentiviral Vectors Market Outlook, 2018 - 2031

  • 7.1. Latin America Lentiviral Vectors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Lentiviral Vector Kits
        • 7.1.1.1.1. Lentiviral Packing Systems
        • 7.1.1.1.2. Lentiviral Expression Systems
        • 7.1.1.1.3. Lentiviral Promoter Kits
        • 7.1.1.1.4. Lentiviral Fusion Tags
      • 7.1.1.2. Reagents & Consumables
  • 7.2. Latin America Lentiviral Vectors Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Cancer
      • 7.2.1.2. Genetic Disorders
      • 7.2.1.3. Infectious Diseases
      • 7.2.1.4. Veterinary Diseases
      • 7.2.1.5. Others
  • 7.3. Latin America Lentiviral Vectors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Biotechnology Companies
      • 7.3.1.2. Pharmaceutical Companies
      • 7.3.1.3. Contract Research Organizations (CROs)
      • 7.3.1.4. Academic and Research Institutes
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Lentiviral Vectors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.2. Brazil Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.4.1.3. Brazil Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.4. Mexico Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.5. Mexico Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.4.1.6. Mexico Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.7. Argentina Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.8. Argentina Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.4.1.9. Argentina Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Lentiviral Vectors Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Lentiviral Vectors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Lentiviral Vector Kits
        • 8.1.1.1.1. Lentiviral Packing Systems
        • 8.1.1.1.2. Lentiviral Expression Systems
        • 8.1.1.1.3. Lentiviral Promoter Kits
        • 8.1.1.1.4. Lentiviral Fusion Tags
      • 8.1.1.2. Reagents & Consumables
  • 8.2. Middle East & Africa Lentiviral Vectors Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cancer
      • 8.2.1.2. Genetic Disorders
      • 8.2.1.3. Infectious Diseases
      • 8.2.1.4. Veterinary Diseases
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa Lentiviral Vectors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Biotechnology Companies
      • 8.3.1.2. Pharmaceutical Companies
      • 8.3.1.3. Contract Research Organizations (CROs)
      • 8.3.1.4. Academic and Research Institutes
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Lentiviral Vectors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.2. GCC Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.4.1.3. GCC Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.4. South Africa Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.5. South Africa Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.4.1.6. South Africa Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.7. Egypt Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.8. Egypt Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.4.1.9. Egypt Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.10. Nigeria Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.11. Nigeria Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.4.1.12. Nigeria Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Lentiviral Vectors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Lentiviral Vectors Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Lentiviral Vectors Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs Indication Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. PerkinElmer Inc. (Sirion-Biotech GmbH)
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. GENEMEDI
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Takara Bio, Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Charles River Laboratories
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Sino Biological Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. OriGene Technologies, Inc.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Cell BioLabs, Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Applied Biological Materials Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!